Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy

Early diagnosis and appropriate therapeutic decisions are required for a successful treatment of irAEs. In addition to staging and follow-up imaging, identification and monitoring of adverse events becomes an important radiologic aspect in oncologic care.